The impact of extent of pancreatic and venous resection on survival for patients with pancreatic cancer-Reference-Cited by-同舟云学术

The impact of extent of pancreatic and venous resection on survival for patients with pancreatic cancer

Published:2019-08 Issue:4 Volume:18 Page:389-394
ISSN:1499-3872
Container-title:Hepatobiliary & Pancreatic Diseases International
language:en
Short-container-title:Hepatobiliary & Pancreatic Diseases International

Author:

Serenari Matteo,Ercolani Giorgio,Cucchetti Alessandro,Zanello Matteo,Prosperi Enrico,Fallani Guido,Masetti Michele,Lombardi Raffaele,Cescon Matteo,Jovine Elio

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference37 articles.

1. Cancer statistics, 2013;Siegel;CA Cancer J Clin,2013

2. Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS);Bockhorn;Surgery,2014

3. Extended pancreatectomy in pancreatic ductal adenocarcinoma: definition and consensus of the International Study Group for Pancreatic Surgery (ISGPS);Hartwig;Surgery,2014

4. Outcomes after extended pancreatectomy in patients with borderline resectable and locally advanced pancreatic cancer;Hartwig;Br J Surg,2016

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Analysis of Complications Following Distal Resections for Neuroendocrine Tumors and Adenocarcinoma: Unveiling the Differences;Medical Science Monitor;2024-07-24

2. Synchronous arterial resection in pancreatic cancer: A case report;Experimental and Therapeutic Medicine;2022-03-15

3. Prognostic relevance of the revised R status definition in pancreatic cancer: meta-analysis;BJS Open;2022-03-08

4. Vascular Resection in Pancreatectomy—Is It Safe and Useful for Patients with Advanced Pancreatic Cancer?;Cancers;2022-02-25

5. Postoperative Outcomes of Tangential versus Segmental Resection and End-to-end Reconstruction of the Superior Mesenterico-Portal Vein During Pancreatoduodenectomy for Pancreatic Adenocarcinoma: A Single-Center Experience;Anticancer Research;2021-09-30